The family that owns a drug company is now being sued over the toll of opioid painkillers in one New York county — and it’s likely to be sued by hundreds more.

Well over 1,000 lawsuits filed by state and local governments blame drug companies for a crisis of addiction and overdoses across the country. Only a few of them have named members of the Sackler family, which owns and controls Purdue Pharma, as defendants.

RELATED: Nearly 30% Of All Opioid Prescriptions Lack Documented Reason

But a new filing by New York’s Suffolk County asserts that family members participated in billing OxyContin as non-addictive even though they knew that was not the case. The claim lays out more detailed allegations about the involvement of the family, which is a funder of museums around the world, including the Smithsonian, New York’s Metropolitan Museum of Art and the Tate Modern in London.

The suit says that the family learned in 1999 that OxyContin was being abused but that a Purdue company official later told a congressional investigation that they were unaware of abuses until 2000.

RELATED: Doctors Informed Of Patient’s Overdose Death Reduced Opioid Prescriptions

A spokesman said the family declined to comment.

Paul Hanly, a lawyer representing Suffolk County, says the roughly 200 other local governments he represents in similar suits will also be going after the Sacklers and that other lawyers will follow.

“It raises the stakes dramatically,” Hanly said. He said that family members took “tens of billions” in profits out of the company — and that they could be forced to give that money back to pay damages and penalties in the lawsuits.

The Suffolk County suit is part of a group of lawsuits working their way through state courts in New York.

A judge in Cleveland is overseeing more than 1,000 similar suits and is pushing the governments and companies that make, distribute and sell opioids to reach a far-reaching settlement in the cases, including payments and changes in business practices in the industry.

Comments

Leave a Reply

Please log in using one of these methods to post your comment:

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s